Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

Journal of Clinical Investigation

Volumn 115, Issue 3, 2005, Pages 610-621

  Mori, Kiyoshi ^a   Lee, H Thomas ^a   Rapoport, Dana ^a   Drexler, Ian R ^a   Foster, Kirk ^a   Yang, Jun ^a   Schmidt Ott, Kai M ^a   Chen, Xia ^a   Jau, Yi Li ^a   Weiss, Stacey ^a   Mishra, Jaya ^b   Cheema, Faisal H ^a   Markowitz, Glenn ^a   Suganami, Takayoshi ^c   Sawai, Kazutomo ^c   Mukoyama, Masashi ^c   Kunis, Cheryl ^a   D'Agati, Vivette ^a   Devarajan, Prasad ^b   Barasch, Jonathan ^a  

^a Columbia University ^*  (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM; HEME OXYGENASE 1; IRON; IRON BINDING PROTEIN; IRON COMPLEX; LIPOCALIN; NERVE CELL ADHESION MOLECULE; SIDEROPHORE; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; COMPLEX FORMATION; ENDOCYTOSIS; IRON BINDING CAPACITY; KIDNEY CORTEX; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; REPERFUSION INJURY; UREMIA; X RAY CRYSTALLOGRAPHY;

EID: 20044395425     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23056     Document Type: Article

References (100)

1. Lieberthal, W., and Nigam, S.K. 2000. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am. J. Physiol. Renal Physiol. 278:F1-F12.
2. Bonventre, J.V. 2003. Dedifferenciation and proliferation of surviving epithelial cells in acute renal failure. J. Am. Soc. Nephrol. 14(Suppl. 1):S55-S61.
3. Schrier, R.W., Wang, W., Poole, B., and Mitra, A. 2004. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest. 114:5-14. doi:10.1172/JCI200422353.
4. Halliwell, B., and Gutteridge, J.M. 1990. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186:1-85.
5. McCord, J.M. 1985. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:159-163.
6. Meneghini, R. 1997. Iron homeostasis, oxidative stress, and DNA damage. Free Radic. Biol. Med. 23:783-792.
7. Baliga, R., Zhang, Z., Baliga, M., and Shah, S.V. 1996. Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int. 49:362-369.
8. Baliga, R., Zhang, Z., Baliga, M., Ueda, N., and Shah, S.V. 1998. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 53:394-401.
9. Saad, S.Y., Najjar, T.A., and Al-Rikabi, A.C. 2001. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol. Res. 43:211-218.
10. Paller, M.S., and Jacob, H.S. 1994. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc. Natl. Acad. Sci. U. S. A. 91:7002-7006.
11. Baliga, R., Ueda, N., and Shah, S.V. 1993. Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem. J. 291:901-905.
12. Baron, P., et al. 1991. Renal preservation after warm ischemia using oxygen free radical scavengers to prevent reperfusion injury. J. Surg. Res. 51:60-65.
13. Alfrey, A.C. 1992. Toxicity of tubule fluid iron in the nephrotic syndrome. Am. J. Physiol. 263:F637-F641.
14. Wu, Z.L., and Paller, M.S. 1994. Iron loading enhances susceptibility to renal ischemia in rats. Ren. Fail. 16:471-480.
15. Walker, P.D., and Shah, S.V. 1988. Evidence suggesting a role for hydtoxyl radical in gentamicin-induced acute renal failure in rats. J. Clin. Invest. 81:334-341.
16. Paller, M.S., and Hedlund, B.E. 1988. Role of iron in postischemic renal injury in the rat. Kidney Int. 34:474-480.
17. Paller, M.S., and Hedlund, B.E. 1994. Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation. Free Radic. Biol. Med. 17:597-603.
18. de Vries, B., et al. 2004. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation. 77:669-675.
19. Zager, R.A., Burkhart, K.M., Conrad, D.S., and Gmur, D.J. 1995. Iron, heme oxygenase, and glutathione: effects on myohemoglobinuric proximal tubular injury. Kidney Int. 48:1624-1634.
20. Horwitz, L.D., et al. 1998. Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 95:5263-5268.
21. Tacchini, L., Fusar Poli, D., Bernelli-Zazzera, A., and Cairo, G. 2002. Transferrin receptor gene expression and transferrin-bound iron uptake are increased during postischemic rat liver reperfusion. Hepatology. 36:103-111.
22. Gunshin, H., et al. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:482-488.
23. Hentze, M.W., et al. 1987. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science. 238:1570-1573.
24. Leibold, E.A., and Munro, H.N. 1988. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl. Acad. Sci. U. S. A. 85:2171-2175.
25. Rouault, T.A., Hentze, M.W., Caughman, S.W., Harford, J.B., and Klausner, R.D. 1988. Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA. Science. 241:1207-1210.
26. Eisenstein, R., and Blemings, K.P. 1998. Iron regulatory proteins, iron responsive elements and iron homeostasis. J. Nutr. 128:2295-2298.
27. Rogers, J., and Munro, H. 1987. Translation of ferritin light and heavy subunit mRNAs is regulated by intracellular chelatable iron levels in rat hepatoma cells. Proc. Natl. Acad. Sci. U. S. A. 84:2277-2281.
28. Ponka, P., Beaumont, C., and Richardson, D.R. 1998. Function and regulation of transferrin and ferritin. Semin. Hematol. 35:35-54.
29. Wu, K.J., Polack, A., and Dalla-Favera, R. 1999. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science. 283:676-679.
30. Konijn, A.M., et al. 1999. The cellular labile iron pool and intracellular ferritin in K562 cells. Blood. 94:2128-2134.
31. Ferris, C.D., et al. 1999. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell Biol. 1:152-157.
32. Hanson, E.S., Rawlins, M.L., and Leibold, E.A. 2003. Oxygen and iron regulation of iron regulatory protein 2. J. Biol. Chem. 278:40337-40342.
33. Hentze, M.W., and Kuhn, L.C. 1996. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 93:8175-8182.
34. Pantopoulos, K., and Hentze, M.W. 1998. Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc. Natl. Acad. Sci. U. S. A. 95:10559-10563.
35. Schalinske, K.L., and Eisenstein, R.S. 1996. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells. J. Biol. Chem. 271:7168-7176.
36. Loncar, R., Flesche, C.W., and Deussen, A. 2004. Myocardial ferritin content is closely related to the degree of ischaemia. Acta Physiol. Scand. 180:21-28.
37. Tacchini, L., Recalcati, S., Bernelli-Zazzera, A., and Cairo, G. 1997. Induction of ferritin synthesis in ischemic-reperfused rat liver: analysis of the molecular mechanisms. Gastroenterology. 113:946-953.
38. Berberat, P.O., et al. 2003. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J. 17:1724-1726.
39. Yang, J., et al. 2002. An iron delivery pathway mediated by a lipocalin. Mol. Cell. 10:1045-1056.
40. Flower, D., North, A., and Sansom, C. 2000. The lipocalin family: structural and sequence overview. Biochim. Biophys. Acta. 1482:9-24.
41. Goetz, D.H., et al. 2002. The neutrophil lipocalin NGAL is abacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell. 10:1033-1043.
42. Loomis, L.D., and Raymond, K.N. 1991. Solution equilibria of enterobactin and metal-enterobactin complexes. Inorg. Chem. 30:906-911.
43. Li, J.Y., et al. 2004. Detection of intracellular iron by its regulatory effect. Am. J. Physiol. Cell Physiol. 287:C1547-C1559.
44. Mishra, J., et al. 2003. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14:2534-2543.
45. Devarajan, P., Mishra, J., Supavekin, S., Patterson, L.T., and Potter, S. 2003. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol. Genet. Metab. 80:365-376.
46. Prozialeck, W.C., Lamar, P.C., and Appelt, D.M. 2004. Differential expression of E-cadherin, N-cadherin and beta-catenin in proximal and distal segments of the rat nephron. BMC Physiol. 4:10-24.
47. Jablonski, P., et al. 1983. An experimental model for assessment of renal recovery from warm ischemia. Transplantation. 35:198-204.
48. Bush, K.T., Tsukamoto, T., and Nigam, S.K. 2000. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am. J. Physiol. Renal Physiol. 278:F847-F852.
49. Marambaud, P., et al. 2003. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell. 114:635-645.
50. Leussink, B.T., et al. 2001. Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicity. Toxicol. Appl. Pharmacol. 175:54-59.
51. Jiang, J., Dean, D., Burghardt, R.C., and Parrish, A.R. 2004. Disruption of cadherin/catenin expression, localization, and interactions during HgC12-induced nephrotoxicity. Toxicol. Sci. 80:170-182.
52. Christensen, E.I., and Maunsbach, A.B. 1981. Dextran is resistant to lysosomal digestion in kidney tubules. Virchows Arch., B, Cell Pathol. 37:49-59.
53. Axelsson, L, Bergenfeldt, M., and Ohlsson, K. 1995. Studies of the release and turnover of a human neutrophil lipocalin. Scand. J. Clin. Lab. Invest. 55:577-588.
54. Sephton, R.G., Hodgson, G.S., De Abrew, S., and Harris, A.W. 1978. Ga67and Fe59 distributions in mice. J. Nucl. Med. 19:930-935.
55. Carrano, C.J., and Raymond, K.M. 1979. Ferric ion sequestering agents. II. Kinetics and mechanism of iron removal from transferrin by enterobacrin and synthetic tricatechols. J. Am. Chem. Soc. 101:5401-5404.
56. Nath, K.A., et al. 1992. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J. Clin. Invest. 90:267-270.
57. Shimizu, H., et al. 2000. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit. Care Med. 28:809-817.
58. Maines, M.D., Mayer, R.D., Ewing, J.F., and McCoubrey, W.K. 1993. Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J. Pharmacol. Exp. Ther. 264:457-462.
59. Fernandez-Pol, J.A. 1978. Isolation and characterization of a siderophore-like growth factor from mutants of SV40-transformed cells adapted to picolinic acid. Cell. 14:489-499.
60. Jones, R., Peterson, C., Grady, R., and Cerami, A. 1980. Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth. J. Exp. Med. 151:418-428.
61. Sturrock, A., Alexander, J., Lamb, J., Craven, C., and Kaplan, J. 1990. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J. Biol. Chem. 265:3139-3145.
62. Rosenthal, E.A., et al. 2001. An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation. 104:2222-2227.
63. Christensen, E.I., et al. 1999. Evidence for an essential role of megalin in transepithelial transport of retinol. J. Am. Soc. Nephrol. 10:685-695.
64. Hilpert, J., et al. 2002. Related expression profiling confirms the role of endocytic receptor megalin in renal vitamin D3 metabolism. Kidney Int. 62:1672-1681.
65. Borghoff, S.J., Short, B.G., and Swenberg, J.A. 1990. Biochemical mechanisms and pathobiology of alpha 2u-globulin nephropathy. Annu. Rev. Pharmacol. Toxicol. 30:349-367.
66. Kozyraki, R., et al. 2001. Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc. Natl. Acad. Sci. U. S. A. 98:12491-12496.
67. Cavaggioni, A., Findlay, J.B., and Tirindelli, R. 1990. Ligand binding characteristics of homologous rat and mouse urinary proteins and pyrazine-binding protein of calf. Comp. Biochem. Physiol. B. 96:513-520.
68. Quadro, L., Hamberger, L, Colantuoni, V., Gottesman, M.E., and Blaner, W.S. 2003. Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knockout mouse models. Mol. Aspects Med. 24:421-430.
69. Weichsel, A., Andersen, J.F., Champagne, D.E., Walker, F.A., and Montfort, W.R. 1998. Crystal structures of a nitric oxide transport protein from a blood-sucking insect. Nat. Struct. Biol. 5:304-309.
70. Allhorn, M., Berggard, T., Nordberg, J., Olsson, M.L., and Akerstrom, B. 2002. Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood. 99:1894-1901.
71. Fluckinger, M., Haas, H., Merschak, P., Glasgow, B.J., and Redl, B. 2004. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob. Agents Chemother. 48:3367-3372.
72. Konopka, K., and Neilands, J.B. 1984. Effect of serum albumin on siderophore-mediated utilization of transferrin iron. Biochemistry. 23:2122-2127.
73. O'Brien, I.G., Cox, G.B., and Gibson, F. 1970. Biologically active compounds containing 2,3-dihydroxybenzoic acid and serine formed by Escherichia coli. Biochim. Biophys. Acta. 201:453-460.
74. Chipperfield, J.R., and Ratledge, C. 2000. Salicylic acid is not a bacterial siderophore: a theoretical study. Biometals. 13:165-168.
75. Moerlein, S.M., Welch, M.J., Raymond, K.N., and Weitl, F.L. 1981. Tricatecholamide analogs of enterobactin as gallium- and indium-binding radiopharmaceuticals. J. Nucl. Med. 22:710-719.
76. Emery, T., and Hoffer, P.B. 1980. Siderophore-mediated mechanism of gallium uptake demonstrated in the microorganism Ustilago sphaerogena. J. Nucl. Med. 21:935-939.
77. Banin, E., Berenshtein, E., Kitrossky, N., Pe'er, J., and Chevion, M. 2000. Gallium-desferrioxamine protects the cat retina against injury after ischemia and reperfusion. Free Radic. Biol. Med. 28:315-323.
78. Liang, M., Croatt, A.J., and Nath. K.A. 2000. Mechanisms underlying induction of heme oxygenase-1 by nitric oxide in renal rubular epithelial cells. Am. J. Physiol. Renal Physiol. 279:F728-F735.
79. Gonzalez-Michaca, L., Farrugia, G., Croatt, A.J., Alam, J., and Nath, K.A. 2004. Heme: a determinant of life and death in renal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 286:F370-F377.
80. Poss, K.D., and Tonegawa, S. 1997. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. U. S. A. 94:10925-10930.
81. Nath, K.A., et al. 2000. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am. J. Pathol. 156:1527-1535.
82. Nath, K.A., et al. 2001. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int. 59:106-117.
83. Kanwar, Y.S. 2001. Heme oxygenase-1 in renal injury: conclusions of studies in humans and animal models. Kidney Int. 59:378-379.
84. Agarwal, A., Balla, J., Alam, J., Croatt, A.J., and Nath, K.A. 1995. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int. 48:1298-1307.
85. Ohta, K., et al. 2000. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am. J. Kidney Dis. 35:863-870.
86. Poss, K.D., and Tonegawa, S. 1997. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U. S. A. 94:10919-10924.
87. Sikorski, E.M., Hock, T., Hill-Kapturczak, N., and Agarwal A. 2004. The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am. J. Physiol. Renal Physiol. 286:F425-F441.
88. Inguaggiato, P., et al. 2001. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int. 60:2181-2191.
89. Hodges, Y.K., Antholine, W.E., and Horwitz, L.D. 2004. Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins. Biochem. Biophys. Res. Commun. 315:595-598.
90. Alcantara, O., Kalidas, M., Baltathakis, I. and Boldt, D.H. 2001. Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron. Exp. Hematol. 29:1060-1069.
91. Ye, Z., and Connor, J.R. 2000. Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res. 28:1802-1807.
92. Kim, B.S., et al. 2002. Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death. Cell. Immunol. 220:96-106.
93. Chong, T.W., Horwitz, L.D., Moore, J.W., Sowter, H.M., and Harris, A.L. 2002. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines. Cancer Res. 62:6924-6927.
94. Devireddy, L.R., Teodoro, J.G., Richard, F.A., and Green, M.R. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science. 293:829-834.
95. Markowitz, G.S., et al. 2003. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 64:281-289.
96. Bundgaard, J.R., Sengelov, H., Borregaard, N., and Kjeldsen, L. 1994. Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils. Biochem. Biophys. Res. Commun. 202:1468-1475.
97. Lee, H.T., Xu, H., Nasr, S.H., Schnermann, J., and Emala, C.W. 2004. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am. J. Physiol. Renal Physiol. 286:F298-F306.
98. Vogel, S., et al. 2002. Retinol-binding protein-deficient mice: biochemical basis for impaired vision. Biochemistry. 41:15360-15368.
99. Maines, M.D. 1981. Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim. Biophys. Acta. 673:339-350.
100. Heinegard, D., and Tiderstrom, G. 1973. Determination of serum creatinine by a direct colorimetric method. Clin. Chim. Acta. 43:305-310.